FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094975 [Registered on: 17/09/2025] Trial Registered Prospectively
Last Modified On: 16/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Evaluate the effect of Ayurvedic drug Lekhaniya Mahakashya and Mustadighan vati in Sthaulya(obesity) 
Scientific Title of Study   Comparative Clinical Evaluation of Lekhaniya Mahakashya and Mustadighan vati in Sthaulya(obesity) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Himani Bhardwaj 
Designation  MD Scholar, Department of Kayachikitsa 
Affiliation  Uttrakhand Ayurveda University, Gurukul Campus, Hardwar 
Address  OPD 5 Department of Kayachikitsa, Uttrakhand Ayurveda University, Gurukul Campus

Hardwar
UTTARANCHAL
249404
India 
Phone  9528529607  
Fax    
Email  bhimani0995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Punita Pandey 
Designation  Professor 
Affiliation  Uttrakhand Ayurveda University, Gurukul Campus, Hardwar 
Address  OPD 5 Department of Kayachikitsa, Uttrakhand Ayurveda University, Gurukul Campus

Hardwar
UTTARANCHAL
249404
India 
Phone  9319394485  
Fax    
Email  pandey.punita62@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Punita Pandey 
Designation  Professor 
Affiliation  Uttrakhand Ayurveda University, Gurukul Campus, Hardwar 
Address  OPD 5 Department of Kayachikitsa, Uttrakhand Ayurveda University, Gurukul Campus

Hardwar
UTTARANCHAL
249404
India 
Phone  9319394485  
Fax    
Email  pandey.punita62@gmail.com  
 
Source of Monetary or Material Support  
Uttrakhand Ayurveda University, Gurukul Campus, Hardwar 249404 
 
Primary Sponsor  
Name  Dr Himani Bhardwaj 
Address  PG Department of Kayachikitsa, Uttrakhand Ayurveda University, Gurukul Campus, Hardwar, UTTRANCHAL 249404 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Himani Bhardwaj  Uttrakhand Ayurveda University, Gurukul Campus, Hardwar  OPD 5 Department of Kayachikitsa, Uttrakhand Ayurveda University, Gurukul Campus
Hardwar
UTTARANCHAL 
09528529607

bhimani0995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee UAU Gurukul Campus,Haridwar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E668||Other obesity. Ayurveda Condition: MEDOVRUDDHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Mustadi Ghanvati, Reference: ch.su.23/13, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -koshana jala), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Lekhaniya Mahakashya, Reference: ch.su.4/8, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)Individuals of either gender between the age group of 20-60 years will be selected
2)Individuals having classical sign and symptoms of Sthaulya(obesity)
3)Individuals between BMI of 25-34.9 will be selected 
 
ExclusionCriteria 
Details  1)K/C/O uncontrolled diabetes, hypothyroidism, hypertension
2)Long term steroid treatment
3)Pregnant and lactating women
4)Individuals having age of less than 18 and more than 60 years
5)cases of alcohol dependence and drug abuse

6)Individuals having BMI more than 34.9
7)obesity due to genetic causes 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relef in following parameters:
1)Swas kasta(breathlessness)
2)Janusandhishoola(pain in both knee joints)
3)Atinidrata(excessive sleep)
4)Kshudaatimatram(increased hunger)
5)Pipasaatiyogam(excessive thirst)
6)Swedadhikiya(excessive sweating)
7)Durgandhyam(foul smell from body)
8)Daurbalya(weakness) 
Assessment of Subjective Parameters at 1st day, 30th day, 60th day, 90th day 
 
Secondary Outcome  
Outcome  TimePoints 
Relief in following parameters
1)Body weight
2)BMI- between 25 to 34.9kg/m2
3)Anthropometry Measurements
a)Skin Fold Thickness measured with digital Vernier Caliper at biceps, triceps, supra-iliac and subscapular region
b)Waist Circumference(more than 90cm in man and 80cm in female)
c)Waist hip ratio(more than 0.88 in male and 0.80 in female) 
Assessment of Subjective Parameters at 1st day and 90th day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is an open-label, double-arm comparative clinical trial to evaluate the efficacy of Lekhaniya Mahakashya and Mustadi Ghanvati in the management oF Sthaulya(obesity). A total of 40 patients will be randomly divided into two groups of 20 each. One group will recieve Lekhaniya Mahakashya kwath and the other group will recieve Mustadi Ghanvati for 90 days.
Assessment will be done on the basis of subjective and objective parameter.
The aim is to compare both drugs and provide safe and efficient ayurvedic intervention of sthaulya.

 
Close